Protagonist Therapeutics
PTGX
#3534
Rank
โ‚ฌ2.48 B
Marketcap
40,54ย โ‚ฌ
Share price
-4.43%
Change (1 day)
58.88%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2024 (TTM): โ‚ฌ0.40 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.39 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ54.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.41 B669.17%
2023 โ‚ฌ54.27 M119.03%
2022 โ‚ฌ24.78 M2.58%
2021 โ‚ฌ24.15 M3.79%
2020 โ‚ฌ23.27 M11187.16%
2019 โ‚ฌ0.2 M-99.24%
2018 โ‚ฌ27.03 M61.67%
2017 โ‚ฌ16.72 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA